- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Neuroectodermal Tumors, Primitive, Peripheral in South Africa
Total 612 results
-
Hoffmann-La RocheCompletedMalignant Melanoma, NeoplasmsUnited States, South Africa, Croatia, Brazil, Egypt
-
Ascentage Pharma Group Inc.Merck Sharp & Dohme LLCRecruitingMelanoma | P53 Mutation | Uveal Melanoma | Cutaneous Melanoma | Mucosal Melanoma | Malignant Peripheral Nerve Sheath Tumors | MPNST | Unresectable or Metastatic Melanoma or Advanced Solid Tumors | MDM2 Gene MutationUnited States, Australia
-
Erasmus Medical CenterRecruitingNeuroendocrine TumorsNetherlands
-
Provectus Biopharmaceuticals, Inc.Active, not recruitingNeuroendocrine Tumors Metastatic to the LiverAustralia
-
Immunolight, LLCRecruitingAdvanced Solid Tumor CancerUnited States
-
Erasmus Medical CenterRecruitingNeuroendocrine Tumors | Peptide Receptor Radionuclide TherapyNetherlands
-
Cellxpert Biotechnology Corp.Medigen Biotechnology CorporationCompletedUnspecified Adult Solid Tumor, Protocol Specific | Melanoma (Skin)Australia, United States
-
Lipotek Pty LtdRoyal Adelaide Hospital; Trident Clinical Research Pty LtdCompleted
-
National Cancer Institute (NCI)Active, not recruitingAdvanced Malignant Solid Neoplasm | Refractory Malignant Solid Neoplasm | Recurrent Malignant Solid Neoplasm | Recurrent Neuroblastoma | Refractory Neuroblastoma | Refractory Non-Hodgkin Lymphoma | Refractory Primary Central Nervous System Neoplasm | Ann Arbor Stage III Childhood Non-Hodgkin Lymphoma and other conditionsUnited States, Puerto Rico
-
Melanoma Institute AustraliaBristol-Myers SquibbRecruiting
-
Prisma Health-UpstateOncolix, Inc.Terminated
-
Medical University of South CarolinaTerminated
-
Melanoma Institute AustraliaNovartisRecruiting
-
QBiotics Group LimitedMerck Sharp & Dohme LLCTerminated
-
ITM Solucin GmbHABX CRO; PSI CROActive, not recruitingNeuroendocrine TumorsGermany, France, United States, United Kingdom, Australia, Italy, Belgium, Switzerland, Czechia, Spain, Austria, Netherlands, Poland, South Africa
-
Medical University of South CarolinaTerminatedGlioma | Astrocytoma | Brain Tumor | Glioblastoma MultiformeUnited States
-
Melanoma Institute AustraliaMerck Sharp & Dohme LLCNot yet recruitingMucosal MelanomaAustralia
-
Provectus PharmaceuticalsCompleted
-
Bristol-Myers SquibbActive, not recruiting
-
QBiotics Group LimitedTerminated
-
Melanoma and Skin Cancer Trials LimitedTrans Tasman Radiation Oncology GroupActive, not recruiting
-
Melanoma Institute AustraliaBristol-Myers SquibbRecruiting
-
National Cancer Institute (NCI)Active, not recruitingCarcinoid Tumor | Neuroendocrine Neoplasm | Colorectal Neuroendocrine Tumor G1 | Gastric Neuroendocrine Tumor G1 | Neuroendocrine Tumor G2United States
-
Sheffield Teaching Hospitals NHS Foundation TrustUniversity of SheffieldCompleted
-
Melanoma Institute AustraliaMerck Sharp & Dohme LLC; NovartisActive, not recruiting
-
Hoffmann-La RocheCompletedMalignant MelanomaUnited States, Australia, Brazil, Spain, South Africa, Ukraine, Bosnia and Herzegovina
-
PfizerCompletedWell-differentiated Pancreatic Neuroendocrine TumorUnited States, China, Czechia, India, Japan, South Africa, Slovakia, France, Norway, Romania, Australia, Belgium, Hungary, Italy, Spain
-
Melanoma and Skin Cancer Trials LimitedRecruitingMetastatic Merkel Cell CarcinomaAustralia
-
Provectus PharmaceuticalsCompleted
-
Melanoma Institute AustraliaMerck Sharp & Dohme LLCActive, not recruitingMelanoma Stage IIIAustralia
-
Anthony Joshua, FRACPSt Vincent's Hospital, SydneyActive, not recruiting
-
University of SydneyMelanoma and Skin Cancer Trials LimitedCompleted
-
Melanoma and Skin Cancer Trials LimitedMelanoma Institute AustraliaCompleted
-
Cellxpert Biotechnology Corp.Medigen Biotechnology CorporationCompletedMelanomaAustralia, United States
-
University of IowaPatient-Centered Outcomes Research Institute; Medical University of South Carolina and other collaboratorsEnrolling by invitationNeuroendocrine Tumors | Neuroendocrine Carcinoma | Lung Neuroendocrine Neoplasm | Gastroenteropancreatic Neuroendocrine TumorUnited States
-
TakedaCompletedMelanoma | NeoplasmsUnited States, Australia
-
CelgeneICON Clinical ResearchCompletedMelanoma | Neoplasm MetastasisAustralia, United Kingdom, Ukraine, Germany, Estonia, Latvia, Lithuania, Netherlands, South Africa
-
Melanoma Institute AustraliaActive, not recruiting
-
Melanoma Institute AustraliaBristol-Myers SquibbRecruitingMelanoma Stage IvAustralia, Norway
-
Jazz PharmaceuticalsCompletedAdvanced Solid Tumor | Metastatic Solid Tumor | Urothelial Cancer | Poorly Differentiated Neuroendocrine Carcinomas | Homologous Recombination Deficient-Positive Malignancies AgnosticUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedBrain Tumor | Central Nervous System TumorUnited States, Canada, Australia, Switzerland, Netherlands, New Zealand
-
Bristol-Myers SquibbMedarexCompletedMelanomaFrance, United States, Australia, Belgium, Germany, South Africa, Canada, Brazil, Czech Republic, Hungary
-
Evaxion Biotech A/SNovotech (Australia) Pty LimitedTerminatedMelanoma Stage IV | Melanoma Stage IIIAustralia
-
Merck Sharp & Dohme LLCActive, not recruitingMelanomaSpain, United States, Australia, France, Israel, Italy, South Africa, Switzerland
-
ActelionCompleted
-
Piramal Enterprises LimitedCompletedMelanomaAustralia, India, New Zealand
-
Hoffmann-La RocheCompletedRenal Cell Carcinoma | Chronic Myelogenous Leukemia | Malignant MelanomaCanada, India, Bulgaria, Russian Federation, Spain, South Africa, Slovakia
-
Merck Sharp & Dohme LLCTerminatedAdvanced/Metastatic MelanomaUnited States, Australia, Chile, France, Germany, Israel, Italy, Korea, Republic of, Norway, South Africa, Spain
-
Eli Lilly and CompanyCompletedMetastatic MelanomaAustralia, United States
-
Kartos Therapeutics, Inc.GlaxoSmithKlineCompletedMelanoma | Cancer | Advanced Solid Tumors | Oncology | Tumors | Advanced Malignancy | Oncology PatientsUnited States, Australia